Women with extremely dense breasts and a high breast cancer risk have a lower risk for advanced cancer when screened by digital breast tomosynthesis than digital mammography, US study findings indicate.

Women who participate in the two most recent screening mammography appointments before a breast cancer diagnosis have a significantly lower risk for death than those who do not attend or only attend one appointment, research shows.

Extending mammography screening to include women in their 40s may reduce breast cancer mortality rates compared with a later screening induction without increasing the risk for overdiagnosis, the UK Age trial investigators report.

Two cancers were detected by mammography alone, three by MRI alone, one by mammogram and MRI, five by ultrasonography and MRI, and six by all three imaging modalities.

Preliminary MASAI trial results indicate that AI-supported mammography has a similar rate of breast cancer detection to standard double reading while reducing the screen-reading workload.

A systematic review and meta-analysis has identified global decreases in breast, cervical, and colorectal cancer screening during the early phase of the COVID-19 pandemic.

In this case, there were 15.0 LYG per mammogram compared with 14.5 LYG per mammogram for White women initiating screening at age 50 years.

A US study has found that breast cancer screening rates declined during the COVID-19 pandemic, with the largest reductions among Black and Latinx women, which may exacerbate pre-existing disparities.

Genetic testing should be expanded to include older women with breast cancer, especially those with triple-negative or estrogen receptor-negative disease, suggest US researchers.

Among the 750 women who received at least one dose of a COVID-19 vaccine in the 90 days before having a screening or diagnostic mammogram at the authors’ institution between January 15 and March 22, 2021, axillary adenopathy was observed in 23 (3.1%), with just two women reporting symptoms.

Using a risk-based approach could help to prioritize mammogram evaluations during periods of decreased capacity, suggests US research published in JAMA Network Open .

The declines in breast cancer screening during the COVID-19 pandemic are more marked among women from minority communities and those living in rural areas, report US researchers.

Individuals with breast cancer and a BRCA1/2 variant experience comparable survival rates whether they are treated with breast-conserving therapy or mastectomy with or without radiotherapy, Chinese researchers suggest.

Black race is a significant predictor of nonadherence to scheduled screening mammography appointments, suggests research.

The early months of the COVID-19 pandemic saw a steep reduction in the number of people undergoing cancer screening tests, although numbers recovered subsequently, suggest data from northeastern USA.

Women with interval breast cancers diagnosed within 1 year of a negative mammogram screening result have poorer disease-specific survival than those with screen-detected cancers, US study findings indicate.

Rates of breast cancer surgery, imaging, and genetic testing in the USA have dropped during the COVID-19 pandemic, study findings suggest.

Click through to read more on this novel mammogram aid

For instance, it is not effective to screen women aged younger than 50 years for breast cancer because the breast tissue of younger women is not as amenable to the current mammogram screening technology which uses low dose X-rays, explained Fern.